Medico Remedies

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
34.06
-0.83 (-2.38%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 1.89 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 36.73% vs 4.15% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 13.49% vs 16.22% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 55.93% vs 40.67% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 29.94% vs 21.74% in Mar 2025

Compare Profit and Loss Results of Medico Remedies
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
206.00
120.00
86.00
71.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
206.00
120.00
86.00
71.67%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-1.00
0.00
0.00%
Raw Materials Consumed
153.00
46.00
107.00
232.61%
Power & Fuel Cost
3.00
4.00
-1.00
-25.00%
Employee Cost
7.00
41.00
-34.00
-82.93%
Operating Expenses
11.00
4.00
7.00
175.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
5.00
3.00
60.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
7.00
-6.00
-85.71%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
189.00
123.00
66.00
53.66%
Operating Profit (PBDIT) excl Other Income
17.00
-2.00
19.00
950.00%
Other Income
5.00
3.00
2.00
66.67%
Operating Profit (PBDIT)
22.00
1.00
21.00
2,100.00%
Interest
1.00
3.00
-2.00
-66.67%
Profit before Depriciation and Tax
21.00
-1.00
22.00
2,200.00%
Depreciation
3.00
8.00
-5.00
-62.50%
Profit Before Taxation & Exceptional Items
18.00
-10.00
28.00
280.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
-33.00
51.00
154.55%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
13.00
-32.00
45.00
140.62%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
42.00
-112.00
154.00
137.50%
Profit Available for appropriations
55.00
-144.00
199.00
138.19%
Appropriations
55.00
-144.00
199.00
138.19%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.58
-9.05
10.63
117.46%
Profit And Loss - Net Sales
Net Sales 206.38 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 36.73% vs 4.15% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 13.49% vs 16.22% in Mar 2025

Profit And Loss - Interest
Interest 1.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 55.93% vs 40.67% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 13.12 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 29.94% vs 21.74% in Mar 2025